Neurostimulator Device Market Share

  • Report ID: 3233
  • Published Date: Jul 23, 2024
  • Report Format: PDF, PPT

Neurostimulator Device Market Share

North American Market Forecast   

The North American neurostimulator device market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the growing rate of neurological illnesses in the region. The rising elderly population in the region, will result in an enormous load of neurological (brain) problems in the near future. The population of the United States is ageing as a result of longer life expectancies and decreasing birthrates. Neurological problems are more common as people get older. Further, Parkinson's disease is the second most prevalent neurodegenerative condition affecting older adults in the area. Many cellular functions that are affected by ageing and predisposed to neurodegeneration also predispose to the aetiology of Parkinson's disease (PD). For instance, both motor and cognitive function are affected by this ageing neurodegenerative illness. Further, a minimally invasive surgical method called deep brain stimulation (DBS) is used to treat Parkinson's disease's neurological symptoms.  In North America, Parkinson's disease (PD), the second most common neurological disorder, is predicted to impact more than 900,000 individuals by the year 2020. Furthermore, there has been surging adoption of robotic surgery is further anticipated to boost the market’s growth in the region.

Europe Market Forecast

The European neurostimulator device market, amongst the market in all the other regions, is projected to grow with the highest CAGR during the forecast period. The growth of the market can be attributed majorly to the surging demand for minimally invasive surgeries. In the European area, the prevalence of the most prevalent chronic conditions that call for less invasive surgeries is increasing, including cancer, renal failure, and heart disease. The incidence of chronic diseases has grown over time, owing to a number of causes, including an ageing population and risk factors associated with lifestyle.  More chronic physical and mental health issues are increasingly prevalent in an ageing society. Further, the oldest population in the world is in Europe, which can be as a result of decreased death rates, and longer average life expectancies brought on by medical progress and rising living standards.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3233
  • Published Date: Jul 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of neurostimulator device is assessed at USD 12.92 Billion.

The neurostimulator device market size was valued at USD 11.44 Billion in 2023 and is expected to reach USD 65.76 Billion by the end of 2036, expanding at around 14.4% CAGR during the forecast period i.e., between 2024-2036. Increasing elderly population and the rising prevalence of neurological disorders are the major factors driving the market growth.

North America is likely to dominate majority industry share by 2036, propelled by growing rate of neurological illnesses in the region.

Medtronic PLC, Abbott Laboratories, Nevro Corp., Liva Nova PLC, Axonics Modulation Technologies Inc., Neuropace Inc., EndoStimInc., NDI Medical, Cochlear Limited, Neuronetics Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample